Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Aardvark Adventures -- Ignore unavailable to you. Want to Upgrade?

To: ~digs who wrote (396)	4/23/2004 9:49:11 PM
From: ~digs	Respond to of 7944

BRKR @ 5.02 +0.24 5.02% 3.91M 4:11 PM Bruker BioSciences Corporation is a tools supplier for life science materials research, with an emphasis on advancing proteomics. bullish engulfing candlestick on daily stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!Ul14!Uk14]&pref=G April 23, 2004--Bruker BioSciences Corporation (Nasdaq: BRKR - News) today announced that it has priced a public offering of 15,000,000 shares of its common stock, 3,000,000 of which are being sold by the Company and 12,000,000 of which are being sold by four selling stockholders, at $4.50 per share, generating net proceeds of approximately $12.6 million to the Company and approximately $50.5 million to the selling stockholders, in the aggregate. The Company has granted the underwriters an option to purchase up to an additional 450,000 shares of common stock and the selling stockholders have granted the underwriters an option to purchase up to an additional 1,800,000 shares of common stock to cover over-allotments, if any, which would generate additional net proceeds to the Company of approximately $1.9 million and additional net proceeds to the selling stockholders of approximately $7.7 million, if exercised in full. biz.yahoo.com formerly BDAL